Cargando…
AR Is Not an Independent Marker for TNBC: The Lesson We Learn From Two PDX Models
Extensive efforts, through cell line-based models, have been made to characterize the androgen receptor (AR) signaling pathway in triple-negative breast cancer (TNBC). However, these efforts have not yet reached a consensus with regards to the mechanism of AR in TNBC. On the other hand, patient-deri...
Autores principales: | Wang, Xiaoqiang, Petrossian, Karineh, Huang, Miao-Juei, Saeki, Kohei, Kanaya, Noriko, Chang, Gregory, George, Somlo, Chen, Shiuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090347/ http://dx.doi.org/10.1210/jendso/bvab048.1636 |
Ejemplares similares
-
SUN-007 Discovery of Novel Signaling Pathways Downstream of PTK6 in TNBC Models
por: Dwyer, Amy, et al.
Publicado: (2019) -
ODP441 NErbB-2 and Androgen Receptor Regulate a Gene Signature Involved in Immune Response and Favorable Outcome in TNBC
por: Elizalde, Patricia, et al.
Publicado: (2022) -
SUN-022 Absence of Neuronal Androgen Receptor (AR) Improves Glucose Homeostasis in Female Mice
por: Morford, Jamie, et al.
Publicado: (2019) -
SUN-739 Next Generation AR Antagonists Increase Systemic Active Glucocorticoid Exposure by Altering Glucocorticoid Metabolism
por: Alyamani, Mohammad, et al.
Publicado: (2020) -
SUN-LB136 A Comparison of Androgen Receptor Splice Variant, AR-V7, and Glucocorticoid Receptor Activity in Prostate Cancer
por: Dash, Amit K, et al.
Publicado: (2020)